Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Expansion system in vitro for hematopoietic stem/progenitor cell

An in vitro expansion and hematopoietic stem technology, applied in the direction of blood/immune system cells, animal cells, vertebrate cells, etc., can solve unseen problems and achieve broad clinical application prospects and good hematopoietic reconstruction ability

Inactive Publication Date: 2012-08-22
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on this amplification system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Expansion system in vitro for hematopoietic stem/progenitor cell
  • Expansion system in vitro for hematopoietic stem/progenitor cell
  • Expansion system in vitro for hematopoietic stem/progenitor cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0031] (1) Experimental materials

[0032] (1) Human umbilical vein endothelial cells were cultured as follows

[0033] (2) Umbilical cord blood was obtained from the Department of Obstetrics and Gynecology, Tangdu Hospital, Fourth Military Medical University

[0034] (3) Reagents:

[0035] M199, fetal bovine serum: Gibco

[0036] StemSpan™ serum-free medium, MethoCult™ GF H4434: Stemcell

[0037] Endothelial Cell Growth Supplement (ECGS): Sigma

[0038] Bovine Serum Albumin (BSA): Sigma

[0039] Type II collagenase: Sigma

[0040] Mitomycin C: Sigma

[0041] CD34 MicroBead Kit: Miltenyi Company

[0042] Separation buffer: PBS+2mM EDTA+0.5% BSA

[0043] Lymphocyte Separation Medium: TBD Company

[0044] PBSA: PBS + 2mM EDTA

[0045] SCF (stem cell factor): recombinant human SCF, Peprotech

[0046] TPO (thrombopoietin): recombinant human TPO, Peprotech

[0047] FL (flt3 ligand): recombinant human FL, Peprotech

[0048] IL-6 (interleukin-6): recombinant human IL-6, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an expansion system in vitro for hematopoietic stem / progenitor cells used for expanding human umbilical cord blood in vitro of soluble fusion protein Dll1-RGD (Hdll1-RGD) of notch ligand of a vascular endothelial cell target. The effective expansion system in vitro is formed by taking human umbilical vein endothelial cells as supporting cells of a cultivation system, jointly applying exogenous growth factors SCF, TOP, FL, IL-6, IL-3 and own developed hDLL1-RGD, and co-cultivating with the hematopoietic stem / progenitor cells. According to the expansion system, the hDll1-RGD target is combined to the surface of a human umbilical vein endothelial cell, activated stimulation aiming at a notch receptor is provided for the hematopoietic stem cells, and self-renewal and propagation of the hematopoietic stem cells are maintained, so that a satisfactory expansion effect and favorable implantation capacity are obtained.

Description

technical field [0001] The invention relates to an in vitro culture method of hematopoietic stem / progenitor cells, in particular to a soluble fusion protein hDll1-RGD of Notch ligand targeting vascular endothelial cells in vitro to expand human umbilical cord blood hematopoietic stem / progenitor cells in vitro. The augmentation system belongs to the field of biotechnology. Background technique [0002] At present, hematopoietic stem cell transplantation has become one of the important methods for the clinical treatment of hematological diseases and malignant tumors. Due to the rich source of cord blood, convenient collection, and weak immunogenicity, it has more advantages than bone marrow and peripheral blood transplantation. However, the content of hematopoietic stem / progenitor cells in umbilical cord blood is low, and it is difficult to meet the needs of adults and patients with large body weight. After transplantation, hematopoietic reconstruction is delayed, and it is di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0789
Inventor 韩骅梁英民田登梅
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com